Stockhub

Revive Therapeutics Ltd.: Revision history

View logs for this page

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

25 September 2022

  • curprev 17:2117:21, 25 September 2022 95.149.241.133 talk 1,520 bytes +1,520 Created page with "== Summary<ref>Source: Yahoo Finance.</ref> == Revive Therapeutics Ltd., a life sciences company, focuses on the research and development of therapeutics for rare disorders and infectious diseases. The company offers cannabinoid pharmaceutical portfolio that focuses on rare inflammatory diseases. It is developing Bucillamine, which is in Phase 3 clinical study for the treatment of infectious diseases, including influenza and COVID-19; Psilocybin that is in Phase 1 clini..."
Retrieved from "https://stockhub.co/research/Revive_Therapeutics_Ltd."